Implant Sciences, a high-tech provider of systems and sensors for homeland security and defense markets, recently declared that its Quantum Sniffer QS-B220 desktop explosives and drugs trace detector has been delivered to a major European airport.
The 2011-launched QS-B220 has been procured by a wide range of corporations and governments. At present, this product is under process of U.S. Transportation Security Administration (TSA) qualification testing for air cargo screening.
According to Implant Sciences' Global VP of Sales and Marketing, Darryl Jones, Radiation concerns form a critical aspect of the European customers’ decision processes. European security equipment purchasers opt for Quantum Sniffers due to the absence of radioactive sources in these devices. In addition to making the product unique, the intuitive and user-friendly interface of desktop model attracts the attention of a large number of customers.
Owing to radiation risks and concerns, the use of X-ray technology was prohibited in European airports by EU for security screening purposes in November 2011.
Implant Sciences' President and CEO, Glenn D. Bolduc stated that the QS-B220 was initially developed for aviation security. The growing market value for the product inspired the company to expand its businesses and product implementation on a global basis.
Launched in May 2011, the QS-B220 is available as a desktop explosives and narcotics trace detector that detects trace amounts of narcotic substances and commercial, military, and homemade explosives using Ion Mobility Spectrometry (IMS). The QS-B220 is free of radioactive materials, in addition to supporting high operational availability and low total cost of ownership.